Literature DB >> 17640475

Prevention of lipopolysaccharide-induced injury by 3,5-dicaffeoylquinic acid in endothelial cells.

Ruo-peng Zha1, Wei Xu, Wen-yi Wang, Li Dong, Yi-ping Wang.   

Abstract

AIM: To investigate the effect of 3,5-dicaffeoylquinic acid (3,5-diCQA) on lipopolysaccharide (LPS)-induced injury in human dermal microvascular endothelial cells (HMEC-1).
METHODS: The anti-oxidant effect was detected using the malondialdehyde (MDA) assay in a rat liver microsome model of lipid peroxidation. Cell viability was analyzed using the 3-(4,5-dimethylthiazol-2-yl)-2,5 diphenyltetrazolium bromide assay. Cell lipid peroxide injury was measured by lactate dehydrogenase (LDH) release. Apoptotic cells were detected by flow cytometry, and confirmed by DNA fragmentation analysis. Caspase-3 activity was measured using a specific assay kit. The level of intracellular reactive oxygen species (ROS) was determined by flow cytometry with a 2,7-dichlorodihydro-fluorescein diacetate fluorescence probe.
RESULTS: The exposure of microsomes to ascorbate-Fe2+ resulted in lipoperoxidation according to an increase in the level of MDA. MDA formation decreased in a dose-dependent manner on treatment with 5, 10, or 50 micromol/L 3,5-diCQA. Treatment with LPS for 16 h resulted in a 60% decrease in cell viability and an increase in LDH release from 47.6% to 61.5%. DNA laddering was observed by agarose gel electrophoresis. The level of apoptotic cells peaked at 27% after treatment with LPS for 12 h. Following treatment with LPS for 12 h, intracellular ROS and caspase-3 activity increased. Pretreatment with 3,5-diCQA at 5, 10, or 50 micromol/L for 1 h attenuated LPS-mediated endothelial cell injury. The anti-apoptotic action of 3,5-diCQA was partially dependent on its capacity for anti-oxidation and the suppression of caspase-3 activity.
CONCLUSION: 3,5-diCQA displays anti-oxidative and anti-apoptotic activity in HMEC-1 due to scavenging of intracellular ROS induced by LPS, and the suppression of caspase-3 activity.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17640475     DOI: 10.1111/j.1745-7254.2007.00595.x

Source DB:  PubMed          Journal:  Acta Pharmacol Sin        ISSN: 1671-4083            Impact factor:   6.150


  6 in total

1.  Geniposide inhibits high glucose-induced cell adhesion through the NF-kappaB signaling pathway in human umbilical vein endothelial cells.

Authors:  Guang-fa Wang; Shao-yu Wu; Wei Xu; Hong Jin; Zheng-guang Zhu; Zhong-huang Li; Yuan-xin Tian; Jia-jie Zhang; Jin-jun Rao; Shu-guang Wu
Journal:  Acta Pharmacol Sin       Date:  2010-08       Impact factor: 6.150

2.  Interleukin-17A is involved in development of spontaneous pulmonary emphysema caused by Toll-like receptor 4 mutation.

Authors:  Qing-qing Wang; Hong-zhen Yang; Han-zhi Liu; Su Mi; Xiao-wei Zhang; Hui-min Yan; Yong-gang Ma; Xiao-xing Wang; Zhuo-wei Hu
Journal:  Acta Pharmacol Sin       Date:  2011-06-27       Impact factor: 6.150

3.  X/XO or H2O2 induced IPEC-J2 cell as a new in vitro model for studying apoptosis in post-weaning piglets.

Authors:  Xuan Cai; Lihui Zhu; Xiaolian Chen; Yongshuai Sheng; Qi Guo; Jian Bao; Jianxiong Xu
Journal:  Cytotechnology       Date:  2014-12-21       Impact factor: 2.058

4.  Pre-protective effect of lipoic acid on injury induced by H2O2 in IPEC-J2 cells.

Authors:  Xuan Cai; Xiaolian Chen; Xiaochun Wang; Congcong Xu; Qi Guo; Lihui Zhu; Shuwen Zhu; Jianxiong Xu
Journal:  Mol Cell Biochem       Date:  2013-02-26       Impact factor: 3.396

5.  Identification of Transient Receptor Potential Vanilloid 3 Antagonists from Achillea alpina L. and Separation by Liquid-Liquid-Refining Extraction and High-Speed Counter-Current Chromatography.

Authors:  Shi-Wei Sun; Rong-Rong Wang; Xiao-Ying Sun; Jia-He Fan; Hang Qi; Yang Liu; Guo-Qing Qin; Wei Wang
Journal:  Molecules       Date:  2020-04-26       Impact factor: 4.411

6.  Inhibition of temperature-sensitive TRPV3 channel by two natural isochlorogenic acid isomers for alleviation of dermatitis and chronic pruritus.

Authors:  Hang Qi; Yuntao Shi; Han Wu; Canyang Niu; Xiaoying Sun; KeWei Wang
Journal:  Acta Pharm Sin B       Date:  2021-08-05       Impact factor: 11.413

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.